A Phase I trial of DFN-19 (dihydroergotamine mesilate) for migraine treatment
Latest Information Update: 06 Feb 2019
At a glance
- Drugs Dihydroergotamine mesilate (Primary)
- Indications Migraine
- Focus Adverse reactions
Most Recent Events
- 31 Jan 2019 New trial record